Stemtech

Stemtech Tax Expense

Income Tax Expense of Stemtech (STEK) as of Oct 19, 2026.

Tax Expense

0.00USD

Last updated:

Income Tax Expense of Stemtech is 2024 0.00 USD. Income Tax Expense of Stemtech was 2023 0.00 USD. It decreases by % lower compared to the previous year.

The Stemtech Tax Expense history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Tax Expense
Date
Tax Expense
Jan 1, 2021
0.00 USD
Jan 1, 2022
95,600.00 USD
Jan 1, 2023
0.00 USD
Jan 1, 2024
0.00 USD
The Stemtech Tax Expense history
YEARTax ExpenseYoY
0.00USD—
0.00USD-100.00%
95,600.00USD—
0.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Stemtech Stock analysis

What does Stemtech do? Stemtech Corp, headquartered in Naples, Florida, develops nutritional supplements focused on supporting stem cell function. The company, listed on 15 September 2014, employs 45 full-time staff and operates internationally through subsidiaries and independent distributors. Its products, marketed under brands like RCM System, Stemflo MigraStem, and Cellect One Rapid Renew, enhance stem cell activity for health renewal. Segments include North America, Latin America, and Asia. Stemtech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Stemtech stock

On Eulerpool you can find the complete historical development of Income Tax Expense Stemtech since 2006 – with annual values, charts, and detailed analysis.

Tax expense represents the total income taxes owed. It reflects the company's tax obligations and effective tax rate.

Income Tax Expense's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Income Tax Expense's Stemtech historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Stemtech

All Key Metrics — Stemtech